Navigation Links
Gastric bypass surgery reduces risk of heart disease

Gastric bypass surgery that is often done as a measure for weight reduction may have the potential to reduce risks of // heart disease.

One of the most common procedures to control morbid obesity is by gastric bypass surgery that reduces the size of the stomach and allows the food to pass to the small intestine much faster. Together with psychological and behavioral support, this procedure has become one of the ways to control obesity through lasting weight loss.

A study done by Stanford University School of Medicine shows that weight loss surgery for the obese people can improve their cardiac risk factors and most significantly improve on their triglycerides and C-reactive protein.

A person is considered obese when he’s got a body mass index of 30 and above, while he’s called morbidly obese with a BMI of 40 and above. Obesity is not only a socially tainted physical feature, recent research also links it with a variety of physical risks like that of cardiovascular disease, diabetes, arthritis, asthma, sleep apnea and even cancer.

The new study shows that obesity surgery is not only good for its cosmetic value and its role in weight loss, it is also important for the reduction in the health risks associated with obesity.

Reference: Stanford University School of Medicine, news release, July 2005

Page: 1

Related medicine news :

1. The Reason For Loss Of Appetite After Gastric Bypass
2. Surgeons Perform Robotic Gastric Bypass Surgery
3. Helicobacter pylori Antibiotic Treatment of Peptic Ulcer May not Prevent Gastric lymphomas
4. New Gastric Cancer Drug Unlikely to Benefit Kidney Cancer Patients
5. Migraine Patients Suffer From Gastric Stasis
6. Gastric Bypass And Laparoscopic Reflux Surgery Gaining Popularity
7. Gastric bypass can cause deficiency of Vitamin A
8. For Super-Obese Patients, Duodenal Switch Beats Gastric Bypass
9. Long-time Gastric Acid Suppression Does Not Increase The Risk Of Cancer
10. Gastric Bypass Surgery May Lead to Increased Kidney Stone Risk
11. Robotically Assisted Colo-resection And Gastric Bypass Surgeries Are Becoming Popular
Post Your Comments:

(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: